Clinical Trial Update: 2 Courses of Concurrent Cisplatin Chemoradiotherapy After Surgery for High-risk Head and Neck Squamous Cell Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating two courses of concurrent cisplatin chemoradiotherapy after surgery for high-risk head and neck squamous cell carcinoma; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Squamous Cell Carcinoma of Head and Neck | Phase 3 | Status: RECRUITING